MOUNTAIN VIEW, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical system firm targeted on remodeling the lives of individuals dwelling with epilepsy, right now introduced it is going to be taking part in the upcoming 4th Annual Wolfe Research Healthcare Conference. Management is scheduled to current on Wednesday, November sixteenth at 2:40 p.m. Eastern Time. A reside webcast of this occasion, in addition to an archived recording, shall be out there on the “Investors” part of the firm’s web site at: https://investors.neuropace.com. The webcasts shall be archived and out there for replay for at least 90 days after the occasion.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical system firm targeted on remodeling the lives of individuals dwelling with epilepsy by decreasing or eliminating the incidence of debilitating seizures. Its novel and differentiated RNS System is the first and solely commercially out there, brain-responsive platform that delivers personalised, real-time therapy at the seizure supply. This platform can drive a greater commonplace of look after sufferers dwelling with drug-resistant epilepsy and has the potential to supply a extra personalised resolution and improved outcomes to the giant inhabitants of sufferers affected by different mind issues.
Investor Contact:
Philip Taylor
Gilmartin Group
[email protected]
